Abbott Laboratories (ABT) Other Working Capital Changes (2009 - 2026)

Abbott Laboratories has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $420.0 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $420.0 million, down 3.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 164.26% YoY), and the FY2025 annual result was $1.3 billion, up 62.69% from the prior year.
• Other Working Capital Changes came in at $420.0 million for Q1 2026 at Abbott Laboratories, down from $836.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2023 to a low of -$1.4 billion in Q4 2023.
• The 5-year median for Other Working Capital Changes is $179.0 million (2023), against an average of $184.0 million.
• Across the five-year window, Other Working Capital Changes jumped 3316.67% in 2022 and tumbled 4260.61% in 2023, its largest moves.
• Abbott Laboratories' Other Working Capital Changes stood at $33.0 million in 2022, then sank by 4260.61% to -$1.4 billion in 2023, then jumped by 112.09% to $166.0 million in 2024, then surged by 403.61% to $836.0 million in 2025, then slumped by 49.76% to $420.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $420.0 million (Q1 2026), $836.0 million (Q4 2025), and -$221.0 million (Q3 2025), per Business Quant data.